Venture Global (NYSE: VG) and Edison settle Calcasieu Pass arbitration, agree to expand LNG deliveries to Italy
Herald Investment Trust (LSE: HRI) board races to build cash war chest as Saba standoff stretches into spring
ABIONYX Pharma (ABNX) achieves sphingomyelin manufacturing breakthrough to advance CER-001 sepsis program
Read More 8 minute read Pharma Industry News ABIONYX Pharma (ABNX) achieves sphingomyelin manufacturing breakthrough to advance CER-001 sepsis program ABIONYX Pharma triples CER-001 sphingomyelin yield with proprietary synthesis, advancing its sepsis programme. Read the full strategic analysis. byVenkateshMarch 27, 2026